Henry Schein advances BOLD plan 

MELVILLE, N.Y. - Henry Schein has reported total net sales of $3.2 billion for the first quarter 2025, with constant currency total net sales increasing 1.4% compared with the same period last year, and as-reported total net sales decreasing 0.1% due to a stronger U.S. dollar. Global Distribution and Value-Added Services sales increased 0.8% in constant currencies. Of that, Global Medical Distribution sales increased 3%, reflecting increased patient traffic to physician offices, strong growth in home solutions business and growth from acquisitions. “We are advancing our BOLD+1 Strategic Plan, which has been refreshed for 2025 to 2027, with our team focused on growing the distribution business through increasing operational efficiency and enhancing customer experience, growing our dental and medical specialty businesses and corporate brand products, and further developing our digital footprint and digital solutions,” said Stanley M. Bergman, chairman of the board and CEO. “We remain committed to our long-term financial goal of high-single-digit to low-double-digit earnings growth by continuing to successfully execute against this strategy.” Henry Schein reported GAAP net income of $110 million for the first quarter 2025 vs. $93 million and non-GAAP net income of $143 million, the same as last year. It reported adjusted EBITDA of $259 million vs. $255 million. The company maintained its financial guidance for 2025, including a 2% to 4% increase in total sales growth over 2024 and a mid-single digit increase in adjusted EBITDA growth.